Cloud Banner

Healthcare

Image

Global Whole Genome Bisulfite Sequencing (WGBS) Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Oct 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Whole Genome Bisulfite Sequencing (WGBS) Market, By Product and Service (DNA Extraction, DNA Fragmentation, DNA Repair, Adapter Ligation, Bisulfite Treatment, PCR Amplification), Application (Stem Cell Applications, Developmental Biology, Early Diagnosis of Diseases, Forensic Science), End User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations) – Industry Trends and Forecast to 2029.

Whole Genome Bisulfite Sequencing (WGBS) Market

Whole Genome Bisulfite Sequencing (WGBS) Market Analysis and Size

Whole genome bisulfite sequencing is a next-generation sequencing technology that uses sodium bisulfite to determine the methylation status of single cytosines prior to high-throughput DNA sequencing. The status of DNA methylation at various genes can reveal information about gene regulation and transcriptional activities.

Data Bridge Market Research analyses that the whole genome bisulfite sequencing (WGBS) market which is expected to grow at a healthy CAGR during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Whole Genome Bisulfite Sequencing (WGBS) Market Scope and Segmentation      

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product and Service (DNA Extraction, DNA Fragmentation, DNA Repair, Adapter Ligation, Bisulfite Treatment, PCR Amplification), Application (Stem Cell Applications, Developmental Biology, Early Diagnosis of Diseases, Forensic Science), End User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Illumina, Inc. (U.S.), Epigentek Group Inc (U.S.), CD Genomics (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Novogene Co., Ltd. (China), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), BGI (China), Nebula Genomics (U.S.), Agilent Technologies (U.S.), Qiagen (Germany), Macrogen Inc. (South korea), Oxford Nanopore Technologies plc. (U.K.), Veritas (U.S.)

Market Opportunities

  • Rise in genome sequencing

Market Definition

Whole genome bisulfite sequencing (WGBS) is a critical technique in methylome research. Although a number of tools have been developed to address the mapping challenges caused by bisulfite treatment, the most recent tools available have not been evaluated in terms of read mapping performance as well as biological insights in multiple mammals.

Global Whole Genome Bisulfite Sequencing (WGBS) Market Dynamics

Drivers

  • Rise in genome sequencing

Genome sequencing enables genome-wide methylation profiling at the single-base level which provides methylation status of every CpG locus including partial methylation domains, gene deserts, remote regulatory elements, others which reveals methylation sequence background and reveals absolute DNA methylation levels. During the forecast period of 2022–2029, these factors are boosting the growth of the whole genome bisulfite sequencing (WGBS) market.

  • Rising applications of whole genome sequencing

Single nucleotide resolution methylation profiling at CG, CHG, and CHH sites. differentially methylated sites linked to experimental treatments or sample conditions, understanding cell differentiation or tissue development mechanisms using methylation profiles and early disease and cancer detection by detecting DNA hypermethylation or hypomethylation. These all are the applications of whole genome sequencing which boost the growth of the market.

Opportunities

  • Rising advanced techniques

The increasing number of research and development activities, as well as the adoption of advanced techniques. For instance, whole genome bisulfite sequencing (WGBS) detects methylated cytosines by pre-sequencing the DNA with sodium bisulfite. WGBS has established itself as the gold standard for studying genome-wide methylation at single base resolution. These will provide various opportunities for the growth of the whole genome bisulfite sequencing (WGBS) market during the forecast period.

Restraints/Challenges

  • Low coverage of whole genome bisulfite sequencing

The use of whole genome bisulfite sequencing has been hampered primarily by its high cost, complex data output, and low required coverage. Many studies using whole genome bisulfite sequencing assays have few or no biological replicates due to the high amount and subsequent cost of DNA input. Bisulfite converts unmethylated cytosines to thymidines, reducing sequence complexity, which can make it difficult to create alignments.

This whole genome bisulfite sequencing (WGBS) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the whole genome bisulfite sequencing (WGBS) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Whole Genome Bisulfite Sequencing (WGBS) Market Scope

The whole genome bisulfite sequencing (WGBS) market is segmented on the basis of product and services, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Service

  • DNA Extraction
  • DNA Fragmentation
  • DNA Repair
  • Adapter Ligation
  • Bisulfite Treatment
  • PCR Amplification

 Application

  • Stem Cell Applications
  • Developmental Biology
  • Early Diagnosis of Diseases
  • Forensic Science

 End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Government Institutes
  • Contract Research Organizations

Whole Genome Bisulfite Sequencing (WGBS) Market Regional Analysis/Insights

The whole genome bisulfite sequencing (WGBS) market is analysed and market size insights and trends are provided by country, product and services, application and end user as referenced above.

The countries covered in the whole genome bisulfite sequencing (WGBS) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the whole genome bisulfite sequencing (WGBS) market due to the surging levels of investment for the development of the healthcare industry along with growth of new technologies.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the increasing number of population suffering from diabetes.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Whole Genome Bisulfite Sequencing (WGBS) Market Share Analysis

The whole genome bisulfite sequencing (WGBS) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to whole genome bisulfite sequencing (WGBS) market.

Some of the major players operating in the whole genome bisulfite sequencing (WGBS) market are:

  • Illumina, Inc. (U.S.)
  • Epigentek Group Inc (U.S.)
  • CD Genomics (U.S.)
  • Thermo Fisher Scientific, Inc. (U.S.)
  • Novogene Co., Ltd. (China)
  • PerkinElmer, Inc. (U.S.)
  • Promega Corporation (U.S.)
  • BGI (China)
  • Nebula Genomics (U.S.)
  • Agilent Technologies (U.S.)
  • Qiagen (Germany)
  • Macrogen Inc. (South korea)
  • Oxford Nanopore Technologies plc. (U.K.)
  • Veritas (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

Factors such as increasing number of research and development activities, as well as the adoption of advanced techniques are the major growth driving factors.
Illumina, Inc. (U.S.), Epigentek Group Inc (U.S.), CD Genomics (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Novogene Co., Ltd. (China), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), BGI (China), Nebula Genomics (U.S.), Agilent Technologies (U.S.), Qiagen (Germany), Macrogen Inc. (South korea), Oxford Nanopore Technologies plc. (U.K.), Veritas (U.S.) are the major companies operating in this market.
North America dominates the whole genome bisulfite sequencing (WGBS) market due to the surging levels of investment for the development of the healthcare industry along with the growth of new technologies.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the increasing number of population suffering from diabetes.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials